Ying-ying Shen

Daping, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Clinical relevance of plasma ADAM-17 with cognition and neurodegeneration in Alzheimer's disease.

Clinical relevance of plasma ADAM-17 with cognition and neurodegeneration in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: February 16, 2025

Temporal Changes in Alzheimer's Disease-Related Biomarkers in the CSF of Cognitively Normal Subjects at Different Ages: The Chongqing Ageing and Dementia Study.

Temporal Changes in Alzheimer's Disease-Related Biomarkers in the CSF of Cognitively Normal Subjects at Different Ages: The Chongqing Ageing and Dementia Study.

Journal: Aging cell

Published: October 16, 2024

Diagnostic potential of urinary CX3CL1 for amnestic mild cognitive impairment and Alzheimer's disease.

Diagnostic potential of urinary CX3CL1 for amnestic mild cognitive impairment and Alzheimer's disease.

Journal: Frontiers in aging neuroscience

Published: September 25, 2024

Decreased serum PF4 levels correlate with cognitive decline and CSF biomarkers in Alzheimer's disease in a Chinese cohort.

Decreased serum PF4 levels correlate with cognitive decline and CSF biomarkers in Alzheimer's disease in a Chinese cohort.

Journal: Experimental gerontology

Published: September 05, 2024

Trajectory of changes in myelin basic protein levels in cerebrospinal fluid during ageing and its association with biomarkers of Alzheimer's disease.

Trajectory of changes in myelin basic protein levels in cerebrospinal fluid during ageing and its association with biomarkers of Alzheimer's disease.

Journal: Translational psychiatry

Published: April 09, 2023

Associations Between Plasma Klotho with Renal Function and Cerebrospinal Fluid Amyloid-β Levels in Alzheimer's Disease: The Chongqing Ageing & Dementia Study.

Associations Between Plasma Klotho with Renal Function and Cerebrospinal Fluid Amyloid-β Levels in Alzheimer's Disease: The Chongqing Ageing & Dementia Study.

Journal: Journal of Alzheimer's disease : JAD

Published: February 13, 2023

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.

Journal: Acta neuropathologica

Published: January 09, 2023

The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer's Disease.

The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: May 23, 2022

The association of serum uric acid with cognitive impairment and ATN biomarkers.

The association of serum uric acid with cognitive impairment and ATN biomarkers.

Journal: Frontiers in aging neuroscience

Published: May 13, 2022

Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease.

Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease.

Journal: Science advances

Published: April 01, 2022

Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.

Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: March 28, 2022

Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid-β deposition in the brain.

Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid-β deposition in the brain.

Journal: CNS neuroscience & therapeutics

Published: March 18, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026